HRB
59
2
ISRG
71
-5
CB
57
2
BBY
52
6
STZ
52
-6
MSFT
48
-9
DOV
65
-4
KMI
69
-2
KO
38
-3
CINF
53
3
CMG
66
-4
EIX
70
3
FIS
51
-4
BSX
64
-3
WMB
68
2
SJM
9
-5
VNO
46
-13
XEL
67
2
PPG
57
-3
LH
40
-5
HRB
59
2
ISRG
71
-5
CB
57
2
BBY
52
6
STZ
52
-6
MSFT
48
-9
DOV
65
-4
KMI
69
-2
KO
38
-3
CINF
53
3
CMG
66
-4
EIX
70
3
FIS
51
-4
BSX
64
-3
WMB
68
2
SJM
9
-5
VNO
46
-13
XEL
67
2
PPG
57
-3
LH
40
-5
Financhill
Back

WisdomTree Global ex-US Qual Div Gr ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
42

DNL
WisdomTree Global ex-US Qual Div Gr ETF

Last Price:
36.30
Seasonality Move:
2.79%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
42
WisdomTree Global ex-US Qual Div Gr ETF (DNL) is a Sell

Is WisdomTree Global ex-US Qual Div Gr ETF a Buy, Sell or Hold?

  • The current WisdomTree Global ex-US Qual Div Gr ETF [DNL] share price is $36.12. The Score for DNL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • DNL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNL Stock Price Chart

What is WisdomTree Global ex-US Qual Div Gr ETF's stock price today?

  • The WisdomTree Global ex-US Qual Div Gr ETF share price today is $36.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNL is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DNL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 29.45 Sell
Chaikin Money Flow: -37792 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.98 - 38.58) Sell
Bollinger Bands (100): (37.74 - 39.74) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DNL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37 Sell
20-day SMA: 37.51 Sell
50-day SMA: 38.37 Sell
200-day SMA: 38.61 Sell
8-day EMA: 36.82 Sell
20-day EMA: 37.44 Sell
50-day EMA: 38.11 Sell
200-day EMA: 38.12 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

WisdomTree Global ex-US Qual Div Gr ETF Earnings Growth & DNL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

WisdomTree Global ex-US Qual Div Gr ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):